Related Experiment Video
Updated: Aug 3, 2026

Establishing a Silicosis Rat Model via Exposure of Whole-Body to Respirable Silica
Published on: October 28, 2022
Targeting the Secretin Receptor in Macrophages Attenuates Silica-Induced Pulmonary Fibrosis
Yaqian Li1, Tian Li2, Fuyu Jin3
1College of TCM, North China University of Science and Technology, Tangshan, China.
Abstract:
Targeting macrophage SCTR mitigates integrated profibrotic, inflammatory, ER stress, and senescent pathways, preserving lung function and revealing a novel therapeutic strategy for silicosis.
Insights
Targeting somatostatin C-type receptor (SCTR) in macrophages reduces lung fibrosis and inflammation in silicosis. This approach preserves lung function, offering a new therapeutic strategy for this occupational lung disease.
Area of Science:
- Pulmonary Medicine
- Immunology
- Cell Biology
Background:
- Silicosis is a progressive occupational lung disease characterized by inflammation, fibrosis, and impaired lung function.
- Macrophage activation plays a central role in the pathogenesis of silicosis, driving fibrotic and inflammatory responses.
- Current treatments for silicosis are limited, highlighting the need for novel therapeutic strategies.
Related Concept Videos
Breathing
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

